Open AccessOpioid use is associated with decreased quality of life in patients with Crohn′s disease
Author(s) -
David Sanford,
Patrick Thornley,
Anouar Teriaky,
Nilesh Chande,
James C. Gregor
Publication year - 2014
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.133020
Subject(s) - medicine , crohn's disease , quality of life (healthcare) , inflammatory bowel disease , disease , prednisone , severity of illness , opioid , gastroenterology , receptor , nursing
Quality of life is an important consideration in the management of patients with Crohn's disease. Previous studies suggest that Crohn's disease patients using opioids may have decreased quality of life and increased risk of mortality. Our aim was to determine the association between health-related quality of life (HRQoL) and opioid use in patients with Crohn's disease while controlling for disease severity.